{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T15:40:18Z","timestamp":1761666018033,"version":"build-2065373602"},"reference-count":5,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jogc.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Obstetrics and Gynaecology Canada"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.jogc.2018.09.011","type":"journal-article","created":{"date-parts":[[2018,12,20]],"date-time":"2018-12-20T23:08:31Z","timestamp":1545347311000},"page":"13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pregnancy Outcomes Following Ulipristal Acetate for Uterine Fibroids: A Systematic Review"],"prefix":"10.1016","volume":"41","author":[{"given":"Funlayo","family":"Odejinmi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7516-9132","authenticated-orcid":false,"given":"Rebecca","family":"Mallick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jogc.2018.09.011_bib0001","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.jogc.2018.05.020","article-title":"Pregnancy outcomes following ulipristal acetate for uterine fibroids: a systematic review","volume":"40","author":"De Gasperis-Brigante","year":"2018","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.jogc.2018.09.011_bib0002","unstructured":"Prescriber. Risk of Serious Liver Injury with Esmya. Available at: https:\/\/www.prescriber.co.uk\/news\/risk-of-serious-liver-injury-with-esmya\/2018. Accessed on October 4, 2018."},{"key":"10.1016\/j.jogc.2018.09.011_bib0003","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jmig.2005.03.011","article-title":"Pregnancy and delivery after laparoscopic myomectomy","volume":"12","author":"Kumakiri","year":"2005","journal-title":"J Minim Invasive Gynecol"},{"key":"10.1016\/j.jogc.2018.09.011_bib0004","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1177\/1745505717740218","article-title":"Is ulipristal acetate the new drug of choice for the medical management of uterine fibroids? Res ipsa loquitur?","volume":"13","author":"Odejinmi","year":"2017","journal-title":"Womens Health (Lond)"},{"key":"10.1016\/j.jogc.2018.09.011_bib0005","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1089\/lap.2013.0490","article-title":"Patients' age, myoma size, myoma location, and interval between myomectomy and pregnancy may influence the pregnancy rate and live birth rate after myomectomy","volume":"24","author":"Zhang","year":"2014","journal-title":"J Laparoendosc Adv Surg Tech A"}],"container-title":["Journal of Obstetrics and Gynaecology Canada"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1701216318307072?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1701216318307072?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T15:33:05Z","timestamp":1761665585000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1701216318307072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":5,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S1701216318307072"],"URL":"https:\/\/doi.org\/10.1016\/j.jogc.2018.09.011","relation":{},"ISSN":["1701-2163"],"issn-type":[{"type":"print","value":"1701-2163"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pregnancy Outcomes Following Ulipristal Acetate for Uterine Fibroids: A Systematic Review","name":"articletitle","label":"Article Title"},{"value":"Journal of Obstetrics and Gynaecology Canada","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jogc.2018.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Society of Obstetricians and Gynaecologists of Canada. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}